WASHINGTON (AP) — President Donald Trump signed legislation Wednesday aimed at helping people with deadly diseases try experimental treatments, calling it a “fundamental freedom” that will offer hope and save lives.
Joined by families dealing with amyotrophic lateral sclerosis, also called Lou Gehrig’s disease, and other diseases, Trump signed the so-called Right to Try bill and said he never understood why the issue had lagged for years and Congress hadn’t acted sooner.
“There were no options. But now you have hope — you really have hope,” Trump said. He noted that “for many years, patients, advocates and lawmakers have fought for this fundamental freedom.”
Joe joined President Trump at the White House along with the McLinn family of Indianapolis as the President signed his bipartisan #RightToTry bill with @senronjohnson into law. pic.twitter.com/KCeIzoWRsY
— Senator Joe Donnelly (@SenDonnelly) May 30, 2018
The bill cleared the House last week following an emotional debate in which Republicans said it would help thousands of people in search of hope. Many Democrats said the measure was dangerous and would give patients false hope.
READ | Bill inspired by Indy boy heads to president's desk | What you need to know about right-to-try legislation
As he distributed pens after signing the bill at a small table, 8-year-old Jordan McLinn of Indianapolis, who suffers from muscular dystrophy, waited to embrace the president, drawing laughter in the auditorium when he put his elbow on the table and held up his chin. Trump hugged McLinn and kissed him on the forehead. “He’s going to be fantastic,” the president told McLinn’s mother.
Great honor to welcome these heroic families to the Vice President’s office today right after @POTUS signed #RightToTry into law. Amid hardship, these families courageously worked to make more medicines available to countless Americans in the years ahead. Job well done! pic.twitter.com/qgWaLTFvzc
— Vice President Mike Pence (@VP) May 30, 2018
The president was joined by Health and Human Services Secretary Alex Azar, Food and Drug Administration Commissioner Scott Gottlieb and some of the bill’s allies in Congress, including Sens. Ron Johnson, R-Wis., and Joe Donnelly, D-Ind.
Trump had supported efforts to gain access to the treatments during his 2016 campaign. In his State of the Union address, the president said people who are terminally shouldn’t have to travel “from country to country to seek a cure.”
The measure would give people diagnosed with life-threatening conditions who have exhausted treatment options the ability to gain access to unproven drugs without first getting permission from the FDA.
New drugs normally undergo years of expensive testing before manufacturers seek and gain FDA approval to market them.
Opponents of the bill said it would empower “fly-by-night physicians” to offer false hope and ineffective drugs to patients who are desperate for treatment. They also said that the bill created the incorrect impression that the FDA serves as a bottleneck that deprives dying patients of unproven options.
FDA figures show it approves 99 percent of the roughly 1,000 requests it receives from doctors annually for so-called “compassionate use” of such treatments. The process generally takes about four days, but permission can be granted immediately by phone in emergencies.
The bill was supported by the libertarian Goldwater Institute and the conservative Americans for Prosperity, which is backed by the wealthy brothers Charles and David Koch. The bill also offers some legal protections for pharmaceutical companies, doctors or others involved in providing the treatment.
MORE TOP STORIES | Teacher, student wounded when another student opened fire at Noblesville middle school| Science teacher Jason Seaman being called a hero for stopping school shooter| Woman can't get DirecTV to cancel service | Four Indiana dog breeders on list of 'Horrible Hundred' puppy mills | CALL 6: Tainted diesel from Kroger gas station in Lebanon damages multiple vehicles
Top Trending Videos
